Aprinoia Therapeutics' Series B Round

Aprinoia Therapeutics raised a round of funding on January 16, 2018.

Aprinoia Therapeutics (新旭生技) is a Taiwan-based clinical-stage neuroscience biotech company, that focuses on tau, alpha-synuclein, and novel targets for neurodegenerative diseases.…

Articles about Aprinoia Therapeutics' Series B Round: